## EXPD: Expeditors International of Was - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 3.5% below STRENGTH zone (4.0-10.0%); PEG 4.90 fails VALUE criteria (<1.0); RSI 70 overbought. Stock is in no-man's land without clear edge. Caution: declining volume (54% of avg), momentum weakening (-4.8% MRS), overbought RSI (70).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($139.91)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 5, Bearish: 0)

**1. Russell Investments Group Ltd. Lowers Stock Position in Expeditors International of Washington, Inc. $EXPD**
- Source: MarketBeat | 20251201T112247 | Neutral | Relevance: 99%
- Russell Investments Group Ltd. significantly reduced its stake in Expeditors International of Washington (NASDAQ:EXPD) by 4.2% in the second quarter of 2025, selling over 10,000 shares. This move leaves Russell Investments with 233,946 shares valued at approximately $26.7 million, while other institutional investors have also adjusted their holdings. The article also details recent dividend announcements, insider selling activities by a VP and a director, and current analyst ratings which collectively suggest a "Hold" consensus for the stock.

**2. 15 High Quality Dividend Stocks for Long-Term Investors**
- Source: Insider Monkey | 20251130T231400 | Bullish | Relevance: 99%
- This article identifies high-quality dividend stocks for long-term investors. It highlights Expeditors International of Washington, Inc. (NYSE:EXPD) as a top choice, detailing its recent financial performance, analyst ratings, and strategic growth in various sectors. The company's share repurchase program and dividends further emphasize its commitment to shareholder returns.

**3. 6 Reasons Why You Should Add Expeditors Stock to Your Portfolio**
- Source: MSN | 20251201T033611 | Bullish | Relevance: 99%
- This article highlights six reasons to consider adding Expeditors International of Washington (EXPD) stock to an investment portfolio. Key factors include its strong Zacks Rank #1 (Strong Buy), impressive earnings outperformance, consistent dividend growth, global logistics market expansion, effective capital management through share buybacks, and its position as a leading non-asset-based logistics provider. These points suggest EXPD offers a compelling investment opportunity due to its financial strength, market position, and shareholder returns.

**4. Expeditors International (EXPD): Assessing Valuation After Analyst Upgrades and Earnings Outlook Boost**
- Source: Yahoo! Finance Canada | 20251201T000900 | Bullish | Relevance: 98%
- Expeditors International (EXPD) has seen significant stock momentum following analyst upgrades and a boosted earnings outlook. While its current Price-to-Earnings (P/E) ratio of 23.3x suggests overvaluation compared to industry peers, a Discounted Cash Flow (DCF) model indicates the stock might be undervalued by approximately 22%. Investors are prompted to consider these differing valuation perspectives.

**5. Expeditors International of Washington, Inc. $EXPD Shares Acquired by Prudential Financial Inc.**
- Source: MarketBeat | 20251130T105005 | Neutral | Relevance: 98%
-  Prudential Financial Inc. increased its stake in Expeditors International of Washington, Inc. by 7.2%, acquiring an additional 5,537 shares for a total of 82,596 shares valued at $9.44 million. The article also details recent insider selling by Director Mark A. Emmert and VP Jeffrey F. Dickerman, as well as the company's dividend announcement and various analyst ratings which collectively give the stock a "Hold" consensus.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Morgan Stanley | $95 | $90 | +6% |
| 2025-11-17 | UBS | $166 | $138 | +20% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Morgan Stanley | main | Underweight |
| 2025-11-17 | UBS | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 2 ($0.93M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (-0.9%)
- Blackrock Inc.: 9.2% (-10.1%)
- State Street Corpora: 5.8% (+5.1%)
- First Eagle Investme: 4.7% (+0.0%)
- LOOMIS SAYLES & CO L: 4.3% (+1.6%)

### Key Risks

1. Valuation stretched: PEG 4.9x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 4.90 signals overvaluation risk, limited margin of safety. Forward P/E 24.6x stretched relative to 2% growth. Quality metrics strong (ROE 36%, ROA 14%). Analyst sentiment positive (2 raises, avg +13%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.5B |
| Beta | 1.14 |
| 52W Range | $100.47 - $151.67 |
| Short Interest | 4.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.90 |
| Forward P/E | 24.6 |
| Current P/E | 24.9 |
| YoY Growth | 1.5% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from 8.3% to 3.5% (-4.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.5pp (needs >4.0% for momentum thesis). MRS_5 (-0.4%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 4.6% shows strong absolute momentum above own 20MA. Outperforming sector by 4.9pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 70, risk of mean reversion. Volume at 54% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.49% (CS: 81) | Neutral |
| RSI_14 | 70.2 | Overbought |
| MACD Histogram | 0.29 | Bullish |
| vs SMA20 | 1.046x | Above |
| vs SMA50 | 1.145x | Above |
| vs SMA200 | 1.233x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $146.45
- **Stop Loss:** $139.91 (4.5% risk)
- **Target:** $152.99 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 76
- **Position Value:** $11,130.20
- **Portfolio %:** 11.13%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-02-24 (Est: $1.43)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.39 | $1.64 | +18.1% |
| 2025Q2 | $1.24 | $1.34 | +7.9% |
| 2025Q1 | $1.35 | $1.47 | +9.1% |
| 2024Q4 | $1.44 | $1.68 | +16.7% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*